#Pharmaceutical Archive

Editorial & Columns

AI-focused Partnerships of Global Pharmaceutical Companies

December 5, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Forex Rate Risk: Measurement and Mitigation by Pharmaceutical Companies in India

September 14, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Different Routes and Same Destination: Indian Pharmaceutical & FMCG Companies in Wellness Segment

August 14, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

India and Group of Seven (G7): Connected through Pharmaceuticals

June 21, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Exchange Rate Fluctuations : Effects on Pharmaceutical Sector in SAARC Nations

May 29, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

India-Australia Economic Cooperation and Trade Agreement & Pharmaceutical Exports from India

May 9, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Patent Expiry & Innovator Pharmaceutical Companies : Mechanisms applied to preserve market dominance

April 24, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Contact Us